Aldeyra Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aldeyra Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aldeyra Therapeutics Inc
Rating: 1.10791675
Author: Trendlyne DVM scores

about

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a tr...

4.19 0.13 (3.20%)

41.81% Fall from 52W High

754.1K

XNAS Volume

XNAS 07 Jan, 2026 3:52 PM (EST)

Not Eligible

Expensive Valuation

5.7 / 100

Technically Neutral

38.7 / 100

No estimates available

Aldeyra Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aldeyra Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a tr...

41.81% Fall from 52W High

SWOT Analysis

Aldeyra Therapeutics Inc Live Price Chart